BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioStrategy Partners - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioStrategy Partners
X-ORIGINAL-URL:https://biostrategypartners.org
X-WR-CALDESC:Events for BioStrategy Partners
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250520T113000
DTEND;TZID=America/New_York:20250520T140000
DTSTAMP:20260403T152441
CREATED:20250424T041222Z
LAST-MODIFIED:20250428T054916Z
UID:1532-1747740600-1747749600@biostrategypartners.org
SUMMARY:To Build or Not To Build: The CLIA Lab Dilemma for Startups
DESCRIPTION:BioStrategy Partners May 2025 Practical Knowledge Series  \n\n\n\nLocation: Center for Diagnostic Discovery (206 Welsh Rd. Horsham\, PA 19044)\n\n\n\nFor entrepreneurs developing diagnostics\, the decision to build an in-house CLIA-certified lab-or to partner with existing labs–can define the trajectory of the business. Our expert panelists will demystify the complexities of the Clinical Laboratory Improvement Amendments (CLIA) framework and explore how it intersects with regulatory pathways for medical devices\, diagnostics\, and lab-developed tests (LDTs). We will dive into strategies for regulatory pathways\, reimbursement\, and how to operationalize your own CLIA-lab vs. how best to outsource your commercial development. With real-world insights from seasoned lab executives and regulatory experts\, this panel will provide you with a clear pathway to appropriately classify your product\, reach your target market\, and decide whether to build\, buy\, or partner3:30pm-4:00pm – Registration 4:00pm-5:00pm – Panel5:00pm-6:00pm – Tour & NetworkingModerator:Alexandra Smythe\, Director of Regulatory Affairs\, IDE GroupSpeakers:Robert Middleberg PhD\, Core Laboratory Director\, NMS LabsMartin Till\, President & CEO\, HNL Lab MedicineRobert Boorstein\, MD\, PhD\, Founder & Director\, ClasGroup LLC.
URL:https://biostrategypartners.org/event/to-build-or-not-to-build-the-clia-lab-dilemma-for-startups/
LOCATION:Center for Diagnostic Discovery\, 206 Welsh Rd.\, Horsham\, Pennsylvania\, 19044\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250422T040000
DTEND;TZID=America/New_York:20250422T130000
DTSTAMP:20260403T152441
CREATED:20241021T060057Z
LAST-MODIFIED:20250416T072808Z
UID:1406-1745294400-1745326800@biostrategypartners.org
SUMMARY:Biolabs Investor Day 2025 featuring Practical Knowledge Series by BioStrategy Partners
DESCRIPTION:BioStrategy Partners is collaborating with Biolabs to host the 2025 Investor Day in Philadelphia at The Curtis. We are hosting our Practical Knowledge Series at Investor Day title: Surviving a Startup Rollercoaster: When to Pivot and When to Double Down. Learn more here.  \nIn today’s uncertain market\, where funding is tight and the conditions shift rapidly\, the ability to pivot isn’t just a strategy—it’s a survival skill. This panel will explore what it truly means to pivot\, debunk the stigma around the word\, and share candid stories from founders who’ve survived under pressure. From running out of cash to responding to unexpected data or industry shifts\, our panel of experts will offer practical advice on developing essential skills to pivot successfully\, staying agile\, and building the collaborative mindset needed to thrive in commercial development. \n 
URL:https://biostrategypartners.org/event/save-the-date-biolabs-investor-day-2025/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250130T063000
DTEND;TZID=America/New_York:20250130T083000
DTSTAMP:20260403T152441
CREATED:20250113T033440Z
LAST-MODIFIED:20250114T205621Z
UID:1429-1738218600-1738225800@biostrategypartners.org
SUMMARY:January 2025 PKS - It's More Than Just a Patent: Demystifying Innovation and Technology Transfer
DESCRIPTION:Location: The Post @ The Curtis (601 Walnut St. Philadelphia\, PA 19106) \n\n\n\n\nInnovation drives progress but turning groundbreaking ideas into real-world solutions requires more than just creativity—it demands collaboration\, strategy\, and an understanding of technology transfer. This process\, particularly in the context of academia\, plays a pivotal role in bridging the gap between research and practical application by fostering partnerships with private industry. Technology transfer is not just about securing patents; it’s about navigating an interdisciplinary process to translate discoveries into products and services that benefit society. We will dive into the technology transfer process and share insights and best practices on IP protection\, startup advisory services\, and negotiating licensing agreements. \n\n\n\nTopics include:Overview of the resources and support provided by tech transfer officesNavigating the tech transfer processPartnering with academic technology transfer offices \n\n\n\n\n\n\n\nAgenda\n\n\n\n\n11:30am-12:00pm – Registration & Lunch\n\n\n\n12:00pm-1:00pm – Panel\n\n\n\n1:00pm-1:30pm – Networking \n\n\n\n\n\n\n**Check spam/junk folder for your tickets after RSVP**
URL:https://biostrategypartners.org/event/january-2025-pks-its-more-than-just-a-patent-demystifying-innovation-and-technology-transfer/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241119T103000
DTEND;TZID=America/New_York:20241119T140000
DTSTAMP:20260403T152441
CREATED:20241020T230812Z
LAST-MODIFIED:20241024T082551Z
UID:1373-1732012200-1732024800@biostrategypartners.org
SUMMARY:Philadelphia Region Ecosystem-wide Biotech Jobs Fair
DESCRIPTION:In collaboration with Biolabs Philadelphia\, we are hosting an ecosystem-wide biotech jobs fair on Tuesday\, November 19th\, 2024. The will feature more than 25 employers and 250 job seekers in the life sciences industry. Additionally\, we are hosting lightning panels exploring scientific and adjacent career pathways along with resume review and mock interview workshops. The job fair will have tables from employers in the region\, as well as tables from our event partners on resources for internships\, peer groups\, and more!\n\nTo learn more\, visit: https://www.phillybiotechjobsfair.com/\n\nFor interested job seekers\, please fill out this form: https://forms.monday.com/forms/7b7e793e77594370f51ece1cd075d6cc?r=use1
URL:https://biostrategypartners.org/event/philadelphia-region-ecosystem-wide-biotech-jobs-fair/
LOCATION:The Curtis Atrium\, 601 Walnut St.\, Philadelphia\, PA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241115T070000
DTEND;TZID=America/New_York:20241115T090000
DTSTAMP:20260403T152441
CREATED:20241022T070714Z
LAST-MODIFIED:20241024T081329Z
UID:1414-1731654000-1731661200@biostrategypartners.org
SUMMARY:BARDA Accelerator Network: Funding and Partnership Opportunities
DESCRIPTION:Learn about the BARDA Accelerator Network’s opportunities for support through acceleration and early-stage funding. \nFeatured Speaker: Dr. Mary Larkin\, PhD\, Program Manager\, Biomedical Advanced Research and Development Authority (BARDA) \nWho we’re looking for: \n\nEarly-stage innovators including academic labs and biotech companies developing technologies aligned with BARDA’s mission\nFor more information on BARDA’s mission and areas of interest\, please visit drive.hhs.gov/partner.html\n\nTopics Include: \n\nNon-dilutive and dilutive funding mechanisms.\nOther opportunities for partnership with BARDA.\nBARDA Accelerator Network resources including acceleration\, early-stage research & development funding\, and 1-on-1 mentorship through its five hubs: drive.hhs.gov/accelerators.html\n\nFormat: \n\n30 minutes virtual presentation & overview of BARDA funding programs and partnership opportunities.\n1-on-1 meetings in Zoom breakout rooms with Dr. Mary Larkin and her team on your project/proposals.\nSign-up here after Registration. Spots are limited.\n\n 
URL:https://biostrategypartners.org/event/barda-accelerator-network-funding-and-partnership-opportunities/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240531T030000
DTEND;TZID=America/New_York:20240531T040000
DTSTAMP:20260403T152441
CREATED:20240723T025801Z
LAST-MODIFIED:20250311T065821Z
UID:811-1717124400-1717128000@biostrategypartners.org
SUMMARY:INVESTMENT TRENDS IN AI-ENHANCED STARTUPS
DESCRIPTION:Artificial intelligence has rapidly taken over the investment world in the past few years. New investments in startups utilizing generative AI are announced every week. Our panel of experts will highlight emerging industry trends in startups with AI and how it has impacted the venture capital world.  We’ll explore the nuances of raising capital with companies utilizing AI and provide tips and perspectives from the angel investor world including key metrics and due diligence for a successful raise.\n\n \n\nModerator: Lewis Katz\, Partner & COO\, BioPhy\n\nPanelists\n\n 	Nuzi Barkatally\, Vice President of Startup Banking\, Life Sciences and Healthcare\, Silicon Valley Bank  \n 	Glen Gaddy Ph.D.\, Managing Member\, Robin Hood Ventures\n 	Jamison Rotz\, Chief Executive Officer\, Nearly Human AI 
URL:https://biostrategypartners.org/event/investment-trends-in-ai-enhanced-startups/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240416T000000
DTEND;TZID=America/New_York:20240416T060000
DTSTAMP:20260403T152441
CREATED:20240729T221005Z
LAST-MODIFIED:20241021T042912Z
UID:994-1713225600-1713247200@biostrategypartners.org
SUMMARY:PHILADELPHIA BIOLABS INVESTOR DAY: PRACTICAL KNOWLEDGE SERIES PANEL
DESCRIPTION:BioStrategy Partners is hosting our Practical Knowledge Series at Biolabs Philadelphia Investor Day 2024. \nVisit: Biolabs Philadelphia to learn more. \nBiolabs’ Mission: More than ever\, great life science startups need extensive investor connections to be successful. That’s why BioLabs joins forces with key local ecosystem partners — drawing on our international network of investor relationships — to bring the money and the talent together. \nThis day will feature: 15 company pitches looking to raise seed to series B funding\, our panel discussion\, and networking with investors\, entrepreneurs\, and industry experts. \nOur Practical Knowledge Series will discuss topics on “Steering it Right: Advisory Boards\, Key Opinion Leaders\, and Corporate Hygiene.” \nTopic: Gathering the right advisory board\, key opinion leaders (KOLs)\, and maintaining corporate cleanliness are crucial in securing an investment raise. Delve into the aspects of corporate governance and industry engagement as our experts discuss the importance of corporate cleanliness\, legal preparation for investment and strategies for effective communication while safeguarding sensitive information. Explore the nuances of advisory boards and key opinion leaders including when to engage them\, managing conflicts of interest\, and leveraging their expertise to grow the company. Gain insights from our expert panelists and discover practical tips for navigating corporate governance and maximizing the impact of advisory boards and KOLs. \n\nModerator: Jay Reilly\, JD\, Saul Ewing Arnstein & Lehr\nPanelists: \n\nSunil Joshi\, MBA\, President\, Strategius\, LLC\nKathie Jordan\, PhD\, Managing Director\, Healthcare Investment Group\, Ben Franklin Technology Partners of Southeastern PA\nJ. David Owens\, President & CEO\, BiologicsMD\, Inc.\n\n\n\nQuestions? Reach out to BioSP (admin@biostrategypartners.org) to learn more about panel and Biolabs (philly@biolabs.io) on inquiries for investors and startups. \n  \n 
URL:https://biostrategypartners.org/event/philadelphia-biolabs-investor-day-practical-knowledge-series-panel-2/
LOCATION:The Curtis Atrium\, 601 Walnut St.\, Philadelphia\, PA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240212T230000
DTEND;TZID=America/New_York:20240213T050000
DTSTAMP:20260403T152441
CREATED:20240729T221238Z
LAST-MODIFIED:20241021T042240Z
UID:996-1707778800-1707800400@biostrategypartners.org
SUMMARY:BIOSP REGIONAL TECHNOLOGY TRANSFER SHOWCASE
DESCRIPTION:An invite-only event for serial entrepreneurs\, early-stage investors\, and tech transfer experts. Featuring poster sessions\, core facility info\, technology pitches\, a panel session\, and carefully curated networking. \nMeet the right people\, learn more about the resources you’ll need to successfully start a life science company with a panel discussion on finding capital\, resources\, and institutional support in the current economy. \nPanel Title: Finding Capital\, Resources\, and Institutional Support in the Current Economy \nTopic: Scientists and entrepreneurs often face the challenge of obtaining financial backing for their technologies such as research funds\, laboratory equipment\, and top-tier talent. In this panel\, we will discuss the current landscape of venture capital investment\, avenues for non-dilutive funding\, and maximizing the ecosystem’s institutional resources and support. Our panel of investors will discuss what VCs are looking for in promising technologies and best practices for landing the deal. Next\, we will touch on potential non-dilutive funding available for founders such the various forms of tax credits. Lastly\, our panelists will discuss our ecosystem’s institutional support and the outlook from both academic and government bodies to facilitate collaboration\, research & development\, and capital investment. \nModerator: Michele Washko\, President & CEO\, Life Science Greenhouse Investments \nPanelists: \n\nLori Krim Gough\, PhD\, Partner\, Epidarex  Capital\nGlen Gaddy\, PhD\, Managing Partner\, Robinhood Ventures\nMichael McCann\, President\, MVM Associates\n\nTo see the recap for the event\, go here: https://www.biolabsinvestorday.com/philadelphia-24
URL:https://biostrategypartners.org/event/biosp-regional-technology-transfer-showcase/
LOCATION:The Curtis Atrium\, 601 Walnut St.\, Philadelphia\, PA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240126T070000
DTEND;TZID=America/New_York:20240126T080000
DTSTAMP:20260403T152441
CREATED:20240723T030047Z
LAST-MODIFIED:20240729T221614Z
UID:814-1706252400-1706256000@biostrategypartners.org
SUMMARY:JAN 2024 PKS - NAVIGATING AI & INNOVATIONS: EMERGING TRENDS ON IP PROTECTION DURING R&D
DESCRIPTION:Navigating AI & Innovations: Emerging trends on IP Protection during R&D \nAs the landscape of R&D evolves\, so do the challenges and opportunities in safeguarding IP. This panel will explore the emerging trends shaping IP protection strategies with a focus on the use of digitalization and AI in diagnostics and therapeutics. Our expert panelists will discuss their experiences while the guidelines for AI are becoming clearer and share methods & tools available to protect your IP during these unprecedented times. Join us to learn how to navigate the future of IP protection for emerging technologies.   \nModerator: \nJacob Waier\, JD \nTechnology Licensing Officer \nPenn State University \nPanelists: \nSean Ritchie\, JD \nCounsel \nSaul Ewing \nDave Latshaw\, PhD MBA \nCo-founder/CEO \nBioPhy \nAlex McGee\, JD \nPartner \nHoward & Howard \nREGISTER HERE!
URL:https://biostrategypartners.org/event/philadelphia-biolabs-investor-day-practical-knowledge-series-panel/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230920T120000
DTEND;TZID=America/New_York:20230920T140000
DTSTAMP:20260403T152441
CREATED:20240729T221822Z
LAST-MODIFIED:20240729T222519Z
UID:1000-1695211200-1695218400@biostrategypartners.org
SUMMARY:SEPTEMBER 2023 PKS: SECRETS OF LIFE SCIENCES INNOVATION IN THE SUBURBS
DESCRIPTION:Secrets of Life Sciences Innovation in the Suburbs Revealed \nJoin us for an unique opportunity to connect with fellow professionals dedicated to advancing life sciences in the suburbs of Philadelphia. Discover the secrets to success as industry pioneers and experts share their insights on securing funding\, navigating regulatory pathways\, and building a powerhouse team of collaborators. Our panel will provide you with the knowledge and connections you need to thrive in this growing and dynamic ecosystem in Greater Philadelphia.  \nModerator: \nJeff Snellenburg \nPresident \nPA Angel Network \n  \nPanelists: \nLou Kassa \nChief Executive Officer \nHepatitis B. Foundation\, Blumberg Institute\, Pennsylvania Biotech Center \n  \nParviz A. Shamlou\, PhD \nVice President and Executive Director \nThomas Jefferson University \nScott Dessain  \nChief Scientific Officer \nOCMS Bio\, LLC \nRegister HERE
URL:https://biostrategypartners.org/event/september-2023-pks-secrets-of-life-sciences-innovation-in-the-suburbs/
LOCATION:Center for Forensic Science Research & Education\, 206 Welsh Rd\, Horsham\, PA\, 19044\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230724T080000
DTEND;TZID=America/New_York:20230724T090000
DTSTAMP:20260403T152441
CREATED:20240729T222751Z
LAST-MODIFIED:20240729T222803Z
UID:1013-1690185600-1690189200@biostrategypartners.org
SUMMARY:FEBRUARY 2023 PKS - NON-DILUTIVE FUNDING AND SUPPORTING RESOURCES FOR STARTUPS
DESCRIPTION:Non-dilutive Funding and Supporting Resources for Startups \nLearn about non-dilutive funding opportunities and resources available to accelerate your technology development and company growth. Our panel of experts will discuss various opportunities from federal and state government including valuable tax credit programs and grants. Additionally\, we will focus on how best to craft a successful SBIR/STTR application and the resources available to help your early-stage startup succeed. \n  \nModerator: \nBryan Tsao\, Ph.D. \nProgram Director \nBioStrategy Partners \nPanelists: \nKelly Wylam \nExecutive Director \nInnovation Partnership \nMichael McCann. \nPresident \nMVM Associates \nEarle Hager \nManaging Partner \nThe Neutrino Donut\, LLC \nREGISTER HERE!
URL:https://biostrategypartners.org/event/february-2023-pks-non-dilutive-funding-and-supporting-resources-for-startups/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230713T030000
DTEND;TZID=America/New_York:20230713T040000
DTSTAMP:20260403T152441
CREATED:20240729T221945Z
LAST-MODIFIED:20240729T221945Z
UID:1003-1689217200-1689220800@biostrategypartners.org
SUMMARY:JULY 2023 PKS - BEST PRACTICES FOR BUILDING CLINICAL TRIAL PROGRAMS FOR EARLY-STAGE STARTUPS
DESCRIPTION:Best practices on building clinical programs for early-stage startups \nAs clinical trials continue to play a vital role in advancing medical research and improving patient care\, it becomes crucial to explore the best practices for designing and implementing effective and efficient clinical trial programs. This panel discussion will delve into the importance of integrating nurses\, diversity\, and strategic marketing into the program strategy\, with a particular focus on early clinical trials.  \nTopics: \n\nKey considerations and best practices for planning clinical trials\nImproving the quality and diversity in clinical trials\nLeveraging strategic marketing to increase patient participation\n\n  \nModerator: \nArt Mallette \nExecutive Director\, Global Lung Cancer \nNovartis \nPanelists: \nLaura Reilly\, RN\, BSN\, MBA \nPresident \nMeniscus Limited \nThais McNeal\, MS \nSenior Director Government & Industry Affairs \nHead of Patient Advocacy\, Alliance Development \nOcugen \nSabina Paglialunga\, PhD \nDirector of Scientific Affairs \nCelerion \nREGISTER HERE!
URL:https://biostrategypartners.org/event/july-2023-pks-best-practices-for-building-clinical-trial-programs-for-early-stage-startups/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230531T110000
DTEND;TZID=America/New_York:20230531T130000
DTSTAMP:20260403T152441
CREATED:20240729T222254Z
LAST-MODIFIED:20240729T222316Z
UID:1006-1685530800-1685538000@biostrategypartners.org
SUMMARY:MAY 2023 PKS: FINDING CAPITAL INVESTMENTS
DESCRIPTION:Finding   Capital Investments  \nIn today’s challenging fundraising climate\, identifying the right investors and securing  venture capital is more crucial than ever for biotech startups to remain competitive in the life sciences industry. Our panel of expert will provide valuable insights into the current market for dilutive capital investment types\, emerging therapeutic areas\, and what investors seek in startup companies.  \nWe invite you to join us on May 31st\, 3pm-5pm at The Wistar Institute (3601 Spruce St.) to gain an understanding of the current state of dilutive capital investments and meet new and established faces in our region’s venture capital scene. \nModerator: \nMichele Washko \nPresident & CEO \nLife Sciences Greenhouse Investments \n  \nPanelists: \nLorenzo Pellegrini\, PhD \nManaging Partner \nHatch Biofund \n  \nFrederick Jones\, MD \nPartner \nBioAdvance \nKathie Jordan\, PhD \nManaging Director \nHealthcare Investment Group \nBen Franklin Technology Partners of Southeastern Pennsylvania \nRegister HERE
URL:https://biostrategypartners.org/event/may-2023-pks-finding-capital-investments/
LOCATION:The Wistar Institute\, 3601 Spruce St\, Philadelphia\, PA\, 19104\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230425T123000
DTEND;TZID=America/New_York:20230425T143000
DTSTAMP:20260403T152441
CREATED:20240729T222446Z
LAST-MODIFIED:20240729T222456Z
UID:1010-1682425800-1682433000@biostrategypartners.org
SUMMARY:APRIL 2023 PKS: LANDING RIGHT: FINDING THE BEST LABORATORY FOR YOUR STARTUP
DESCRIPTION:Landing Right: Finding the Best Laboratory for your Startup \nLooking to take your biotech innovation to the next level? Don’t miss out on this BIoStrategy Partner’s Practical Knowledge Series evening event for a discussion on biotech incubators and finding the best fit for your company and technology. A biotech incubator provides access to infrastructure\, resources\, and a collaborative environment which can be the difference between success and failure in the competitive industry. Our expert panelists will share their extensive knowledge on different types of incubators and laboratory-as-a-service options\, how their functionality\, advantages\, and all the resources they offer tenants. You’ll learn about shared labs in Greater Philadelphia\, including SmartLabs and the Center for Diagnostic Discovery. \nJoin us on April 25th from 4:30pm – 6:30pm at 901 Walnut St. Philadelphia\, PA 19107\, Ground Floor\, to learn more about choosing the right laboratory for successful research and development. \nModerator: \nMatthew Gardner \nHead of Advisory Life Sciences\, Americas \nCBRE \n  \nPanelists: \nDaisy Riquelme\, PhD \nHead of Channel Partnerships \nSmartLabs \n  \nEric Rieders\, PhD \nOwner/Operator \nNMS Labs \nArt Howe \nCo-founder of Imvax \nManaging Partner \nDream Garden Consultants \nRegister HERE
URL:https://biostrategypartners.org/event/april-2023-pks-landing-right-finding-the-best-laboratory-for-your-startup/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230127T020000
DTEND;TZID=America/New_York:20230127T030000
DTSTAMP:20260403T152441
CREATED:20240729T232314Z
LAST-MODIFIED:20240729T232314Z
UID:1016-1674784800-1674788400@biostrategypartners.org
SUMMARY:JANUARY 2023 PKS: INNOVATION BASICS AND BEST PRACTICES FOR TECHNOLOGY TRANSFER
DESCRIPTION:Innovation Basics and Best Practices for Technology Transfer \nJoin us to learn about the fundamentals of turning a scientific discovery and research into innovations for the marketplace. Our panel of well-known experts includes a technology transfer expert\, a life-science patent attorney\, and a prolific academic inventor. Our panel will address the questions innovators face after they generate intellectual property and explore strategies you should consider as you advance intellectual property from proof of concept into a technology for commercialization. \nModerator: \nPatrick J. Kelly\, Ph.D.\, J.D. \nCounsel \nArmstrong Teasdale \n  \nPanelists: \nZev Sunleaf \nVice President\, Technology Transfer\, Commercialization & Research Contracts \nChildren’s Hospital of Philadelphia \n  \nIsidore Rigoutsos\, Ph.D. \nRichard W. Hevner Professor in Computational Medicine \nDirector of Computational Medicine Center \nProfessor of Department of Pathology and Genomic Medicine \nThomas Jefferson University \nREGISTER HERE!
URL:https://biostrategypartners.org/event/january-2023-pks-innovation-basics-and-best-practices-for-technology-transfer/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221206T110000
DTEND;TZID=America/New_York:20221206T133000
DTSTAMP:20260403T152441
CREATED:20240729T232551Z
LAST-MODIFIED:20240729T232551Z
UID:1018-1670324400-1670333400@biostrategypartners.org
SUMMARY:DECEMBER 2022 PKS: PREPARING YOUR BIOTECH FOR GROWTH AND COMMERCIAL SUCCESS
DESCRIPTION:Growing an early-stage biotech company is often unpredictable and requires careful planning to ensure success in advancing your technology. Engaging the right partners and preparation for potential risks in your business model is crucial to the survival of biotech companies. Our panel of experts will discuss the current growing pains in the region as well as provide best practices on planning for growth and finding the right partners to develop your technology. We will discuss considerations for potential risks at various stages of growth and how to sustain your companies’ growth in the current competitive market. \nRegister HERE for free.
URL:https://biostrategypartners.org/event/december-2022-pks-preparing-your-biotech-for-growth-and-commercial-success/
LOCATION:12 Spring Mill Dr.\, 12 Spring Mill Dr\, Malvern\, PA\, 19355\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220923T080000
DTEND;TZID=America/New_York:20220923T090000
DTSTAMP:20260403T152441
CREATED:20240729T232811Z
LAST-MODIFIED:20240729T232811Z
UID:1021-1663920000-1663923600@biostrategypartners.org
SUMMARY:SEPTEMBER 2022 PKS: FINDING SUCCESS THROUGH INTERNATIONAL COLLABORATIONS
DESCRIPTION:Finding Success through International Collaborations \nThe growing global life sciences market has led to many academic labs and company executives looking overseas for better market opportunities and collaborations for drug development. However\, institutional barriers often limit productive collaborations between the US and other countries. Our panel of experts will discuss the reasons to look for international collaborations and the best practices for establishing an international presence. We will discuss considerations for intellectual property and strategic partnerships as well as regulatory differences for drug approvals. \nJoin us\, Friday\, September 23rd\, 12PM-1PM to learn more on best practices for establishing international collaborations. \nModerator: \nVered Nohi \nExecutive Director \nPhiladelphia-Israel Chamber of Commerce \nPanelists: \nBlandine Chantepie-Kari \nProgram Manager\, International Programs & ENRICH in the USA \nTemple University Small Business Development Center \nPierre-Olivier Lugez \nSenior Director\, International Business & Global Strategy \nCity of Philadelphia\, Department of Commerce \nREGISTER HERE!
URL:https://biostrategypartners.org/event/september-2022-pks-finding-success-through-international-collaborations/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220826T080000
DTEND;TZID=America/New_York:20220826T090000
DTSTAMP:20260403T152441
CREATED:20240729T232940Z
LAST-MODIFIED:20240729T232940Z
UID:1024-1661500800-1661504400@biostrategypartners.org
SUMMARY:AUGUST 2022 PKS: CREATING EFFECTIVE MARKETING STRATEGIES FOR YOUR TECHNOLOGY
DESCRIPTION:Creating Effective Marketing Strategies for your Technology \nHaving a marketing strategy is crucial for the growth of a biotech company during the R&D phase.  Effective corporate and public communication strategies will help build credibility and trust in the technology and in the company. Our panel of experts will discuss how to approach marketing strategies at different phases of the startup such as academic labs with new intellectual property\, companies in stealth mode\, and companies planning for major venture capital investments or before IPO. Moreover\, we will discuss how to partner with various marketing and public relations firms to effectively communicate the science to the target audience as well as knowing when and how to engage with investors. \nJoin us\, Friday\, August 26th 12PM-1PM EST to learn more on how to develop marketing and communication strategies. \nModerator: \nSteve Nappi \nAssociate Vice President for Technology Commercialization and Business Development \nTemple University \nPanelists: \nSusan Wingeron \nPresident \nSciStrategy Communications \nRobert Flamm \nSVP Head of Corporate Relations \nBurns McClellan \nREGISTER HERE!
URL:https://biostrategypartners.org/event/august-2022-pks-creating-effective-marketing-strategies-for-your-technology/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220714T080000
DTEND;TZID=America/New_York:20220714T090000
DTSTAMP:20260403T152441
CREATED:20240729T233316Z
LAST-MODIFIED:20240729T233421Z
UID:1026-1657785600-1657789200@biostrategypartners.org
SUMMARY:JULY 2022 PKS: RAISING CAPITAL IN THE CURRENT MARKET CONDITIONS
DESCRIPTION:Raising Capital in Current Market Conditions \n  \nSecuring capital and finding the right investors are crucial steps toward a successful startup. The recovery from the pandemic and the current state of the market has left many questions about the state of venture capital and dilutive funding. Our panel of experts will discuss the impact of the current market on the different dilutive capital investment types and provide some pathways to navigate deal searches to secure funding. Moreover\, we will discuss the current trend in various life science/med-tech areas\, what investors look for in startup companies\, and tips on finding the best investors suited for your company. \nJoin us Thursday\, July 14th\, to learn about the current state of dilutive capital investments \nPanelists: \nFrederick Jones\, MD \nPartner \nBioAdvance \nMike Cerminaro \nPresident and COO \nThrombolex \nAnurag Agarwal\, PhD \nPrincipal\, Life Science \nOsage University Partners \n  \nREGISTER HERE!
URL:https://biostrategypartners.org/event/july-2022-pks-raising-capital-in-the-current-market-conditions/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220624T040000
DTEND;TZID=America/New_York:20220624T130000
DTSTAMP:20260403T152441
CREATED:20240729T233616Z
LAST-MODIFIED:20240729T233616Z
UID:1029-1656043200-1656075600@biostrategypartners.org
SUMMARY:JUNE 2022 PKS: PREPARING FOR THE FUTURE OF RARE DISEASES
DESCRIPTION:Preparing for the Future of Rare Diseases \nThe rare disease market is one of the fastest-growing therapeutic market sectors due to favorable government policies and the increasing numbers of rare disease cases globally. \nWhile a rare disease is defined as a condition that affects less than 200\,000 people in the United States\, it is estimated that more than 300 million people suffer from rare diseases globally. Shockingly\, more than 70% of rare diseases do not have a treatment\, suggesting a relatively untapped market. \nOur panel of experts will discuss the different approaches to rare disease therapeutics including IP considerations\, the different types of therapeutics available\, what investors look for in early-stage therapeutics and what resources are available for academic labs studying rare diseases. \nModerator: \nPatrick Kelly\, PhD\, JD\, Counsel\, Stradley Ronon \nPanelists: \nMarni Falk\, MD\, Executive Director\, Mitochondrial Medicine Frontier Program\, Distinguished Chair in the Department of Pediatrics\, The Children’s Hospital of Philadelphia \nDalfoni Banerjee\, Principal Consultant & CEO\, 3Sixty Pharma Solutions LLC \nIhor Terleckyj\, PhD\, Principal\, Valhalla Consulting Group\, Catalyst Pharma \nREGISTER HERE!
URL:https://biostrategypartners.org/event/june-2022-pks-preparing-for-the-future-of-rare-diseases/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220415T080000
DTEND;TZID=America/New_York:20220415T090000
DTSTAMP:20260403T152441
CREATED:20240729T233737Z
LAST-MODIFIED:20240729T233737Z
UID:1031-1650009600-1650013200@biostrategypartners.org
SUMMARY:APRIL 2022 PKS: STARTUP LOCATIONS AND MANUFACTURING NEEDS
DESCRIPTION:Considerations for Startup Locations and Manufacturing Needs \nLooking to grow your business? Successful development of your technology needs essential support systems such as incubators and accelerators at strategic locations to help foster entrepreneurship and collaboration. Our panel of experts will address concepts to consider for determining locations at various stages of a startup from post-launch to scaling your commercial product. We will discuss the types of facilities available for R&D\, quality control\, and manufacturing as well as benefits and incentives to different funding programs that can help grow your startup. \nModerator: \nMichael Maloney \nSenior Vice President at CBRE \nPanelists: \nTerry Jacobs \nPartner/Owner at Jacobs/Wyper Architects \nJeff DeVuono \nExecutive Vice President & Senior Managing Director at Brandywine realty Trust \nAnthony Maher \nPartner/President at University Place Associates \nREGISTER HERE!
URL:https://biostrategypartners.org/event/april-2022-pks-startup-locations-and-manufacturing-needs/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220318T080000
DTEND;TZID=America/New_York:20220318T090000
DTSTAMP:20260403T152441
CREATED:20240729T233910Z
LAST-MODIFIED:20240729T233910Z
UID:1033-1647590400-1647594000@biostrategypartners.org
SUMMARY:MARCH 2022 PKS: BASICS OF LAUNCHING A DIGITAL HEALTH STARTUP AND CURRENT TRENDS
DESCRIPTION:Basics of Launching a Digital Health Startup and Current Trends\n \nDigital healthcare investments and startups have blossomed the past couple years. Propelled by the onset of the pandemic\, the life science biotech and healthcare industry went through a massive digital transformation and are increasingly reliant on digital innovations to make healthcare systems more scalable\, accessible and equitable\, while increasing the quality of outcomes across the board. Our panel of experts in the digital health space will discuss the current trends in digital healthcare\, regulatory considerations\, customer market research and the basics of launching a sustainable startup with digital innovations. \nMODERATOR: \nAron Starosta\, PhD\nVice President of Commercialization and New Ventures at University City Science Center\n \nPANELISTS:\nGlen Gaddy\, PhD\nManaging Member at Robin Hood Ventures\n \nJessie Garcia\nFounder of Tozuda Inc.\n \nTroy Wilford\, MBA\nDirector of Commercialization Solutions at University City Science Center\n \nREGISTER HERE!
URL:https://biostrategypartners.org/event/march-2022-pks-basics-of-launching-a-digital-health-startup-and-current-trends/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220218T070000
DTEND;TZID=America/New_York:20220218T080000
DTSTAMP:20260403T152441
CREATED:20240729T234034Z
LAST-MODIFIED:20240729T234341Z
UID:1035-1645167600-1645171200@biostrategypartners.org
SUMMARY:FEBRUARY 2022 PKS: NON-DILUTIVE FUNDING AND STARTUP SUPPORT PROGRAMS
DESCRIPTION:Non-dilutive Funding and Startup Support Programs\n \nNeed capital for your early stage startup? You can’t afford to miss this webinar! You will learn about various non-dilutive funding mechanisms through federal\, state and foundation programs to commercialize your innovation and grow your startup. Our diverse panel includes experts in federal funding programs and educational resources; public and private foundations looking to advance solutions within their special interest; and federal and state government programs that support early stage startups\, including valuable tax credit programs. \nMODERATOR:Mary Fuchs\, MBA\nBusiness Relationship Advisor at AOIC\, LLC\n \nPANELISTS:\nMichael McCann\nPresident at MVM Associates\, Inc.\n \nChristina Pellicane\, MBS\nAssistant Director of Innovation at Princeton University\n \nKen Kilgore\, PhD\, MBA\nChief Scientific Investment Officer at Beyond Celiac\n \nREGISTER HERE!
URL:https://biostrategypartners.org/event/february-2022-pks-non-dilutive-funding-and-startup-support-programs/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220114T070000
DTEND;TZID=America/New_York:20220114T080000
DTSTAMP:20260403T152441
CREATED:20240729T234458Z
LAST-MODIFIED:20240729T234458Z
UID:1038-1642143600-1642147200@biostrategypartners.org
SUMMARY:JANUARY 2022 PKS: STARTUP BASICS
DESCRIPTION:Startup Basics and the Current State of Biotech Startups and IP\n \nJoin us to learn about the fundamentals of creating and building a startup. Our panel of experts encompasses the startup essentials which include a Director of a Technology Transfer office\, a life-science patent attorney\, an academic inventor\, and an entrepreneur at a biotech. This diverse panel of experts will provide a comprehensive overview of the startup creation process and the current state of startups after a couple of tumultuous years in life science industry. \nMODERATOR: \nErika Swift\, MBA\nOperations Director at Center for Medical Innovation\, Penn State College of Medicine. Board member and President at BioStrategy Partners \nPANELISTS:\nPatrick Kelly\, PhD\, JD\nCounsel at Stradley Ronon \nCarlos Barrero\, MD\nAssistant Professor at Temple University School of Pharmacy \nMatthew Handel\, MSChief Executive Officer at ExpressCells. Board Director at PolyAurum\n \nREGISTER HERE!
URL:https://biostrategypartners.org/event/january-2022-pks-startup-basics/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211112T070000
DTEND;TZID=America/New_York:20211112T080000
DTSTAMP:20260403T152441
CREATED:20240729T234608Z
LAST-MODIFIED:20240729T234608Z
UID:1040-1636700400-1636704000@biostrategypartners.org
SUMMARY:NOVEMBER 2021 PKS: PREPARING FOR AN EXIT
DESCRIPTION:The Light at the End of the Tunnel: Preparing for an Exit Strategy\n \nOne of the most important decisions in a startup life cycle is determining the appropriate time for an exit strategy. From mergers & acquisitions to IPOs\, the best exit strategies will require a careful assessment of the startup’s strengths\, circumstances and various available financial options. Learn from different perspectives including an entrepreneur\, an investor and a financial expert about the comprehensive preparation that goes into exit strategies. \nMODERATOR: \nFrederick “Rick” Jones\, MD\, MBA\nPartner at BioAdvance\, an early-stage life science venture fund. Former Director at Broadview Ventures. Prior to that\, held executive positions in small biotech and big pharma after starting his career as an internal medicine physician. \nPANELISTS:\nWendy DiCicco\nExecutive & Board Advisory Consultant at Board Advantage\, LLC. Board Member at Imvax\, Inc\, Eye Point Pharmaceuticals\, Sincerus Pharmaceuticals and ExpressCells. Interim CFO for Renovacor. Financial Advisor for Danforth Advisors. Former Board Member for Carmell Therapeutics\, II-VI Incorporated\, and SynCardia Systems\, Inc. \nMichael Markus\, PhD\nVP & General Manager at Vapotherm Access (formerly HGF Digital Health). Co-Founder & Managing Director at GeneSyn IP Ventures. Executive Director at 2Zmedical (Medical Device company for Respiratory Health & Digital Medicine). \nREGISTER HERE!
URL:https://biostrategypartners.org/event/november-2021-pks-preparing-for-an-exit/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211022T080000
DTEND;TZID=America/New_York:20211022T090000
DTSTAMP:20260403T152441
CREATED:20240729T234757Z
LAST-MODIFIED:20240729T234757Z
UID:1042-1634889600-1634893200@biostrategypartners.org
SUMMARY:OCTOBER 2021 PKS: THE RIGHT FIT – SELECTING A CRO
DESCRIPTION:Tips for Selecting and Working with a Contract Research Organization (CRO)\n \nCROs and related businesses known as CMOs and CDMOs are a critical part of the life sciences ecosystem\, offering everything from laboratory services for early-stage companies operating virtually to post-marketing surveillance for global pharmaceutical companies and everything in between. Not all are created alike\, however. Learn about the important differences among them\, how to select the right partner for your technology and tips for optimizing the relationship. \nMODERATOR: \nTina Catalone\, PhD\, PMP\, Senior Medical Innovation Program Manager\, Center for Medical Innovation\, Penn State College of Medicine\n \nPANELISTS: \nStephen Parent\, PhD\, Co-Founder\, VP Business Strategy & Development – Concurrent\, Kathera Biosciences Inc. \nNina Seme Nelson\, PhD\, Drug Discovery Leader\, Early Phase Development Solutions Team\, Labcorp Drug Development (Covance)\n \nREGISTER HERE!
URL:https://biostrategypartners.org/event/october-2021-pks-the-right-fit-selecting-a-cro/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210917T080000
DTEND;TZID=America/New_York:20210917T090000
DTSTAMP:20260403T152441
CREATED:20240729T235018Z
LAST-MODIFIED:20240729T235018Z
UID:1044-1631865600-1631869200@biostrategypartners.org
SUMMARY:SEPTEMBER 2021 PKS: MEDICAL DIAGNOSTICS AND INTELLECTUAL PROPERTY
DESCRIPTION:Making Sense of a Complex Landscape\n \nDevelopers of Medical Diagnostics face a complex and rapidly evolving intellectual property landscape. Successful commercialization of discoveries in this space requires an understanding of: \n\nThe pathway from biomarker to diagnostic tool\nHow IP aligns with clinical needs\nExpectations of commercialization partners\n\nThis month’s panel features a combination of legal\, industry\nand tech transfer experts who will share their knowledge of\nthis unique and important subsector of the life sciences. \nMODERATOR: \nPatrick J. Kelly\, Counsel\, Stradley Ronon \nPANELISTS: \nRianne Esquivel\, PhD\, Scientific Affairs Manager\, Fujirebio US\nJames Major\, DPhil\, Associate\, Stradley Ronon\nHeather Steinman\, PhD\, MBA\, Vice President for Business Development & Executive Director\, Technology Transfer\, The Wistar Institute \nREGISTER HERE!
URL:https://biostrategypartners.org/event/september-2021-pks-medical-diagnostics-and-intellectual-property/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210730T040000
DTEND;TZID=America/New_York:20210730T130000
DTSTAMP:20260403T152441
CREATED:20240729T235218Z
LAST-MODIFIED:20240729T235218Z
UID:1046-1627617600-1627650000@biostrategypartners.org
SUMMARY:JULY 2021 PKS: FINDING TALENT IN A COMPETITIVE MARKETPLACE
DESCRIPTION:How do you turn great science into a great business? By pooling the efforts and expertise of talented individuals. \nDuring this panel we’ll explore how to:\n \n\nIdentify and prioritize the skills and expertise needed to grow a life science business\nStrategies for finding and attracting the right hires \nCreative approaches to tapping professional expertise \nRegional workforce initiatives and training programs geared towards the life sciences industry\n\nPANELISTS: \n\nPatricia Day\, Manager\, Leadership Engagement\, The Chamber of Commerce for Greater Philadelphia\nEmma Thorp\,Chief Growth Officer\, RBW Consulting\, Boston and San Diego\n\nJames Pietropaolo\, Associate Director\, Office of Entrepreneurship and Commercialization\, Penn State University\n\nREGISTER HERE!
URL:https://biostrategypartners.org/event/july-2021-pks-finding-talent-in-a-competitive-marketplace/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210618T080000
DTEND;TZID=America/New_York:20210618T090000
DTSTAMP:20260403T152441
CREATED:20240729T235317Z
LAST-MODIFIED:20240729T235317Z
UID:1048-1624003200-1624006800@biostrategypartners.org
SUMMARY:JUNE 2021 PKS: WORKING WITH TECHNOLOGY TRANSFER OFFICES
DESCRIPTION:Best Practices for Faculty and Founders\n \nResearchers and would-be life sciences company founders\, this panel is designed especially for you! Learn directly from technology transfer professionals at some of Pennsylvania’s premier institutions how\, when and why to work with technology transfer offices to optimize the power of invention. \nTopics to be explored include:\n \n\nTips for effective communication with Technology Transfer Offices\nThe relationships among invention disclosures\, patents\, publications\, copyrights and trade secrets\nPatenting processes\, including timing and costs\nCommon myths about intellectual property\n\nPANELISTS: \n\nCamille Jolly-Tornetta\, PhD\, Director\, Office of Technology Transfer\, Children’s Hospital of Philadelphia\nTim Hurley\, Associate Director\, Office of Technology Management\, Penn State University\nNiraj J. Muni\, PhD\, MBA\, Associate Director\, Technology Commercialization\, Temple University\n\n\nREGISTER HERE!
URL:https://biostrategypartners.org/event/june-2021-pks-working-with-technology-transfer-offices/
LOCATION:Pennsylvania
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210521T080000
DTEND;TZID=America/New_York:20210521T090000
DTSTAMP:20260403T152441
CREATED:20240729T235533Z
LAST-MODIFIED:20240729T235533Z
UID:1050-1621584000-1621587600@biostrategypartners.org
SUMMARY:MAY 2021 PKS: RAISING EARLY-STAGE CAPITAL – **VIEW THE RECORDING!**
DESCRIPTION:What You Need to Know about Angel Investment and Seed-Stage Venture Funding\n \nYou’ve invested both cash and sweat equity into your emerging life sciences company\, right? It’s likely you’ve received grant funding\, too\, as well as investment from “friends and family.” Nevertheless\, you’re going to need more money to reach the milestones that tend to attract a majority of venture capitalists (VCs) and strategic partners. \nWhere are you going to find that critical early-stage capital? We’ll discuss the people and organizations that typically invest in companies at this stage\, where to find them and tips for cultivating effective relationships. We’ll also explore the current investment climate and planning for future capital needs. \nMODERATOR: \n\nHeather Hunter\, Vice President\, Communications\, Venatorx Pharmaceuticals\n\nPANELISTS: \n\nFrederick (Rick) Jones\, Partner\, BioAdvance\nMark Mitchell\, Managing Director & Screening Committee Chair\, Delaware Crossing Investor Group\nJoseph P Hackett\, Director South Central Region\, Executive in Residence\, JD Brown Center for Entrepreneurship at York College of Pennsylvania\, Ben Franklin Technology Partners\n\nREGISTER HERE!
URL:https://biostrategypartners.org/event/may-2021-pks-raising-early-stage-capital-view-the-recording/
LOCATION:Pennsylvania
END:VEVENT
END:VCALENDAR